Error: Could not add to watchlist. X

Biocancell Ltd

+ Watchlist
BICL:IT
Tel Aviv
96.10
ILs
1.30
1.33%
As of 10:24:06 ET on 07/30/2015.
Open
97.40
Day Range
94.80 - 98.00
Volume
14,800
Previous Close
97.40
52Wk Range
91.40 - 221.94
1 Yr Return
-52.20%
Open
97.40
Day Range
94.80 - 98.00
Volume
14,800
Previous Close
97.40
52Wk Range
91.40 - 221.94
1 Yr Return
-52.20%
YTD Return
-11.34%
Current P/E Ratio (TTM)
-
Earnings per Share (ILS) (TTM)
-0.89
Market Cap (m ILs)
46.985
Shares Outstanding (m)
48.892
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
BioCancell Ltd. is a biopharmaceutical company that develops targeted cancer therapy treatments for numerous types of cancer. The treatment is based on utilizing a target gene, such as the H19 gene, an oncofetal gene expressed at high levels in over 40 types of human cancer tissues, while existing at a nearly undetectable level in the surrounding normal tissues.
ADDRESS
8 Hartom St
Jerusalem, 97775
Israel
PHONE
972-2-548-6555
  • Jonathan Burgin
    Chief Executive Officer
  • Avraham Hochberg
    Chief Scientist/Co-Founder
  • Monique Ben-Am
    VP:Clinical Development
Show More